Total Payments
$504.14
2024 Payments
$448.79
Companies
6
Transactions
10
Medicare Patients
1,126
Medicare Billing
$76,221
Payment Breakdown by Category
Food & Beverage$504.14 (100.0%)
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Food and Beverage | $504.14 | 10 | 100.0% |
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| ShockWave Medical, Inc | $346.84 | 2 | $0 (2024) |
| Merck Sharp & Dohme LLC | $42.82 | 2 | $0 (2024) |
| Amgen Inc. | $41.26 | 2 | $0 (2024) |
| Lilly USA, LLC | $37.98 | 2 | $0 (2024) |
| Bayer Healthcare Pharmaceuticals Inc. | $18.57 | 1 | $0 (2023) |
| Amarin Pharma Inc. | $16.67 | 1 | $0 (2022) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2024 | $448.79 | 7 | ShockWave Medical, Inc ($346.84) |
| 2023 | $18.57 | 1 | Bayer Healthcare Pharmaceuticals Inc. ($18.57) |
| 2022 | $36.78 | 2 | Lilly USA, LLC ($20.11) |
All Payment Transactions
10 individual payment records from CMS Open Payments
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 11/10/2024 | ShockWave Medical, Inc | Shockwave IVL System with the Shockwave C2 Coronary IVL Catheter (Device) | Food and Beverage | In-kind items and services | $186.17 | General |
| Category: Lithoplasty | ||||||
| 11/10/2024 | ShockWave Medical, Inc | Shockwave IVL System with the Shockwave C2 Coronary IVL Catheter (Device) | Food and Beverage | In-kind items and services | $160.67 | General |
| Category: Lithoplasty | ||||||
| 11/08/2024 | Merck Sharp & Dohme LLC | VERQUVO (Drug), VERQUVO | Food and Beverage | In-kind items and services | $23.67 | General |
| Category: CARDIOVASCULAR | ||||||
| 11/05/2024 | Amgen Inc. | Repatha (Biological) | Food and Beverage | In-kind items and services | $24.82 | General |
| Category: Cardiology | ||||||
| 10/07/2024 | Amgen Inc. | Repatha (Biological) | Food and Beverage | In-kind items and services | $16.44 | General |
| Category: Cardiology | ||||||
| 09/16/2024 | Merck Sharp & Dohme LLC | VERQUVO (Drug), VERQUVO | Food and Beverage | In-kind items and services | $19.15 | General |
| Category: CARDIOVASCULAR | ||||||
| 04/05/2024 | Lilly USA, LLC | MOUNJARO (Drug) | Food and Beverage | In-kind items and services | $17.87 | General |
| Category: Diabetes | ||||||
| 09/21/2023 | Bayer Healthcare Pharmaceuticals Inc. | Kerendia (Drug) | Food and Beverage | In-kind items and services | $18.57 | General |
| Category: Cardio-renal | ||||||
| 07/29/2022 | Lilly USA, LLC | MOUNJARO (Drug) | Food and Beverage | In-kind items and services | $20.11 | General |
| Category: Diabetes | ||||||
| 02/10/2022 | Amarin Pharma Inc. | Vascepa (Drug) | Food and Beverage | In-kind items and services | $16.67 | General |
| Category: Cardiovascular | ||||||
Medicare Billing by Year
| Year | Procedures | Beneficiaries | Services | Submitted | Medicare Paid |
|---|---|---|---|---|---|
| 2023 | 7 | 301 | 465 | $70,994 | $25,403 |
| 2022 | 8 | 316 | 436 | $59,240 | $22,987 |
| 2021 | 5 | 183 | 209 | $33,006 | $9,679 |
| 2020 | 11 | 326 | 433 | $69,439 | $18,153 |
Total Patients
1,126
Total Services
1,543
Medicare Billing
$76,221
Procedure Codes
31
All Medicare Procedures & Services
31 procedure records from CMS Medicare Utilization — Page 1 of 2
| HCPCS | Description | Setting | Year | Patients | Services | Charges | Medicare Paid | Ratio |
|---|---|---|---|---|---|---|---|---|
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2023 | 165 | 312 | $51,134 | $16,150 | 31.6% |
| 90677 | Pneumococcal conjugate vaccine, 20 valent (pcv20), for intramuscular use | Office | 2023 | 14 | 14 | $4,749 | $3,663 | 77.1% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2023 | 44 | 53 | $6,166 | $2,258 | 36.6% |
| 99215 | Established patient office or other outpatient visit, 40-54 minutes | Office | 2023 | 16 | 17 | $3,866 | $1,555 | 40.2% |
| G0439 | Annual wellness visit, includes a personalized prevention plan of service (pps), subsequent visit | Office | 2023 | 26 | 26 | $4,311 | $1,224 | 28.4% |
| G0009 | Administration of pneumococcal vaccine | Office | 2023 | 18 | 18 | $595.94 | $468.74 | 78.7% |
| 81002 | Urinalysis, manual test | Office | 2023 | 18 | 25 | $173.00 | $85.25 | 49.3% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2022 | 143 | 238 | $37,726 | $14,238 | 37.7% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2022 | 69 | 83 | $9,441 | $3,826 | 40.5% |
| 99215 | Established patient office or other outpatient visit, 40-54 minutes | Office | 2022 | 13 | 18 | $3,975 | $1,727 | 43.5% |
| 99204 | New patient office or other outpatient visit, 45-59 minutes | Office | 2022 | 25 | 25 | $4,940 | $1,501 | 30.4% |
| G0439 | Annual wellness visit, includes a personalized prevention plan of service (pps), subsequent visit | Office | 2022 | 14 | 14 | $2,257 | $1,160 | 51.4% |
| G0009 | Administration of pneumococcal vaccine | Office | 2022 | 11 | 11 | $360.47 | $299.19 | 83.0% |
| 93000 | Routine electrocardiogram (ecg) using at least 12 leads with interpretation and report | Office | 2022 | 16 | 18 | $347.08 | $138.97 | 40.0% |
| 81002 | Urinalysis, manual test | Office | 2022 | 25 | 29 | $193.63 | $96.14 | 49.7% |
| 99214 | Established patient outpatient visit, total time 30-39 minutes | Office | 2021 | 65 | 78 | $16,511 | $4,800 | 29.1% |
| 99213 | Established patient outpatient visit, total time 20-29 minutes | Office | 2021 | 58 | 64 | $9,032 | $2,798 | 31.0% |
| 99215 | Established patient outpatient visit, total time 40-54 minutes | Office | 2021 | 19 | 22 | $6,606 | $1,874 | 28.4% |
| 93000 | Routine ekg using at least 12 leads including interpretation and report | Office | 2021 | 13 | 14 | $640.03 | $113.42 | 17.7% |
| 36415 | Insertion of needle into vein for collection of blood sample | Office | 2021 | 28 | 31 | $217.00 | $93.00 | 42.9% |
| 99214 | Established patient office or other outpatient, visit typically 25 minutes | Office | 2020 | 121 | 194 | $45,110 | $10,578 | 23.4% |
| 99213 | Established patient office or other outpatient visit, typically 15 minutes | Office | 2020 | 46 | 55 | $8,690 | $2,082 | 24.0% |
| G0439 | Annual wellness visit, includes a personalized prevention plan of service (pps), subsequent visit | Office | 2020 | 17 | 17 | $4,216 | $1,582 | 37.5% |
| 99215 | Established patient office or other outpatient, visit typically 40 minutes | Office | 2020 | 11 | 15 | $4,665 | $1,315 | 28.2% |
| 90662 | Vaccine for influenza for injection into muscle | Office | 2020 | 20 | 22 | $2,640 | $1,311 | 49.7% |
About Rina Rousek, APRN
Rina Rousek, APRN is a Nurse Practitioner healthcare provider based in Makawao, Hawaii. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 01/18/2016. The National Provider Identifier (NPI) number assigned to this provider is 1235596560.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Rina Rousek, APRN has received a total of $504.14 in payments from pharmaceutical and medical device companies, with $448.79 received in 2024. These payments were reported across 10 transactions from 6 companies. The most common payment nature is "Food and Beverage" ($504.14).
As a Medicare-enrolled provider, Rousek has provided services to 1,126 Medicare beneficiaries, totaling 1,543 services with total Medicare billing of $76,221. Data is available for 4 years (2020–2023), covering 31 distinct procedure/service records.
Ad
Practice Information
- Specialty Nurse Practitioner
- Other Specialties Nurse Practitioner
- Location Makawao, HI
- Active Since 01/18/2016
- Last Updated 12/23/2021
- Taxonomy Code 363L00000X
- Entity Type Individual
- NPI Number 1235596560
Products in Payments
- Shockwave IVL System with the Shockwave C2 Coronary IVL Catheter (Device) $346.84
- VERQUVO (Drug) $42.82
- Repatha (Biological) $41.26
- MOUNJARO (Drug) $37.98
- Kerendia (Drug) $18.57
- Vascepa (Drug) $16.67
Explore
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.